T1	Participants 0 39	Anaerobic infection in cancer patients:
T2	Participants 168 253	cancer patients having localized infections presumably caused by anaerobic pathogens.
T3	Participants 258 382	rates of favorable response were 89% in patients receiving clindamycine alone and 78% in patients receiving cefoxitin alone.
T4	Participants 479 570	20 of 24 patients (83%) responded to clindamycin and 18 of 22 (82%) responded to cefoxitin.
